Metronidazole may prolong the PT in patients receiving warfarin or other coumarin anticoagulants.
Metronidazole (and potentially ronidazole), may prolong INR/PT in patients taking coumarin anticoagulants; avoid concurrent use if possible; otherw...
Metronidazole (and potentially tinidazole) may prolong the prothrombin time (PT) in patients taking warfarin or other coumarin anticoagulants.
Potential for reduced anticoagulant effect
Potential for decreased anticoagulant efficacy if carbimazole added
Rare reports of increased anticoagulant effect
Increased risk for bleeding; clopidogrel may interfere with metabolism
Concomitant use of danazol with anticoagulants may enhance the anticoagulant effect as danazol may decrease the synthesis of procoagulant factors ...
Dantrolene may be displaced from plasma proteins by warfarin with increased effects or adverse reactions resulting dantrolene sodium 251
Dicloxacillin may cause decreased warfarin efficacy
Oral anticoagulant activity may be decreased if estrogens are administered concurrently; increases in anticoagulant dosage may be necessary if addi...
Potential for increased warfarin effects
Potential for increased warfarin effects
Erythromycin may potentiate the effects of oral anticoagulant drugs Erythromycin can inhibit the metabolism of other drugs that use the CYP3A subfa...
Oral anticoagulant activity may be decreased if estrogens are administered concurrently; increases in anticoagulant dosage may be necessary if addi...
Etodolac may increase the risk for bleeding
Use with NSAIDs may increase the risk for bleeding
Fluoxetine may increase the risk for bleeding
Fluvoxamine may increase the risk for bleeding
May increase the risk for hemorrhage